Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTSH-Assisted Iodine-131 Therapy for Differentiated Thyroid Cancer (Observational Cohort)
ChiCTR2600126471Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of thyrotropin alfa in well-differentiated thyroid cancer (WDTC), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Adverse reactions and TSH level. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
thyrotropin alfa
03
Conditions
well-differentiated thyroid cancer (WDTC)
Beyond the preview
Go deeper on ChiCTR2600126471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126471.